内视镜逆行性造影市场规模、份额、成长分析（按产品类型、程序、最终用户和地区）- 2025 年至 2032 年产业预测

Endoscopic Retrograde Cholangiopancreatography Market Size, Share, and Growth Analysis, By Product Type (Endoscopes, Endotherapy Devices), By Procedure (Biliary Sphincterotomy, Biliary Stenting), By End Users, By Region - Industry Forecast 2025-2032

出版日期: 2025年04月02日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计 2023 年全球内视镜逆行性造影市场规模将达到 15 亿美元，从 2024 年的 16.5 亿美元成长到 2032 年的 34.8 亿美元，预测期内（2025-2032 年）的复合年增长率为 9.8%。

微创手术的日益普及导致对内视镜逆行性胰造影(ERCP) 手术的需求大幅增加，这使得该领域在未来几年将迎来强劲增长。 ERCP 之所以受欢迎，是因为它比传统手术具有优势，包括恢復时间更短、併发症发生率更低。美国癌症协会最近发布的数据预计 2023 年美国将新增约 41,210 例肝癌病例，凸显了这些进展的迫切性。这项统计数据凸显了对复杂诊断和治疗方案日益增长的需求，并强调了在 ERCP 市场持续投资和创新的重要性。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲国家
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业市场定位（2024年）
主要市场参与者所采取的策略
近期市场趋势
公司市场占有率分析（2024年）
主要企业简介
- 公司详情
- 产品系列分析
- 公司分部份额分析
- 收益与前一年同期比较对比（2022-2024 年）
  主要企业简介
  - 奥林巴斯株式会社（日本）
  - 美国康美德公司
  - 富士软片控股株式会社（日本）
  - 豪雅株式会社（日本）
  - 波士顿科学公司（美国）
  - 强生公司（美国）
  - 美敦力公司（爱尔兰）
  - 库克医疗（美国）
  - STERRIS PLC（美国）
  - TeleMed Systems Inc.（美国）
  - DCC Healthcare (Medi-Globe GmbH)（爱尔兰）
  - 惠格医疗器材有限公司 (中国)
  - 索诺斯凯医疗公司（中国）
  - KARL STORZ SE & Co. KG（德国）
  - Ambu A/S（丹麦）
  - B.Braun Melsungen AG（德国）
  - 宾得医疗（日本）
  - 日立有限公司（日本）
  - 佳能医疗系统株式会社（日本）
  - 索尼公司（日本）

结论和建议

简介目录

Product Code: SQMIG35A2748

Global Endoscopic Retrograde Cholangiopancreatography Market size was valued at USD 1.5 billion in 2023 and is poised to grow from USD 1.65 billion in 2024 to USD 3.48 billion by 2032, growing at a CAGR of 9.8% during the forecast period (2025-2032).

The rising popularity of minimally invasive surgical techniques has led to a significant uptick in the demand for endoscopic retrograde cholangiopancreatography (ERCP) procedures, positioning this sector for robust growth in the coming years. The preference for ERCP is driven by its benefits, such as shorter recovery periods and decreased complication rates compared to traditional surgery. Recent data from the American Cancer Society highlights the urgency for such advancements, as the U.S. anticipates approximately 41,210 new liver cancer cases in 2023. This statistic underlines the increasing necessity for sophisticated diagnostic and therapeutic options, reinforcing the importance of ongoing investments and innovations within the ERCP market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Endoscopic Retrograde Cholangiopancreatography market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Endoscopic Retrograde Cholangiopancreatography Market Segments Analysis

Global Endoscopic Retrograde Cholangiopancreatography Market is segmented by Product Type, Procedure, End Users and region. Based on Product Type, the market is segmented into Endoscopes, Endotherapy Devices, Visualization Systems, Energy Devices and Others. Based on Procedure, the market is segmented into Biliary Sphincterotomy, Biliary Stenting, Biliary Dialtation, Pancreatic Sphincterotomy, Pancreatic Duct Stenting and Pancreatic Duct Dilatation. Based on End Users, the market is segmented into Hospitals, Ambulatory Surgery Centers & Clinics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Endoscopic Retrograde Cholangiopancreatography Market

The global endoscopic retrograde cholangiopancreatography (ERCP) market is propelled by the increasing demand for advanced diagnostic and therapeutic solutions targeting the pancreas, liver, gallbladder, and bile ducts. ERCP is a sophisticated procedure that combines luminal endoscopy and fluoroscopic imaging, allowing for effective identification and treatment of pancreatobiliary disorders. This technique involves the use of a flexible, illuminated endoscope, which navigates through the digestive tract for direct visualization of critical organs, while simultaneously capturing X-ray images. The ability to provide comprehensive assessments and interventions drives the growth of the ERCP market, catering to the rising needs of healthcare providers worldwide.

Restraints in the Global Endoscopic Retrograde Cholangiopancreatography Market

The growth of the Global Endoscopic Retrograde Cholangiopancreatography market is being restrained by stringent regulatory guidelines enforced by governing bodies in various countries, which create obstacles for the introduction of new technologies. Adhering to these regulations necessitates extensive testing and compliance with safety and efficacy standards, resulting in a complicated and time-consuming approval process for novel medical innovations. Despite these regulatory challenges, there are positive developments within the market. Notably, the increase in disposable income, particularly in developing nations, has emerged as a significant driver of market expansion, indicating potential for future growth despite existing constraints.

Market Trends of the Global Endoscopic Retrograde Cholangiopancreatography Market

The Global Endoscopic Retrograde Cholangiopancreatography (ERCP) market is set to flourish, driven by innovative strategic initiatives from leading industry players. Notable activities, such as product launches, mergers, and acquisitions, are transforming the landscape. For instance, the April 2022 partnership between Olympus and EndoClot Plus, which introduced the EndoClot PHS, exemplifies the market's focus on enhancing therapeutic endoscopic solutions. This collaboration emphasizes the shift towards nonthermal, nontraumatic techniques for efficient hemostasis in gastrointestinal procedures. As healthcare providers increasingly prioritize advanced and effective treatments, the ERCP market is poised for substantial growth, reflecting a commitment to improving patient outcomes and enhancing procedural safety.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Case Studies

Global Endoscopic Retrograde Cholangiopancreatography Market Size by Product Type & CAGR (2025-2032)

Market Overview
Endoscopes
Endotherapy Devices
- Sphincterotomes
- Lithotripter
- Stents
- Cannulas
- Forceps
- Snares
- Catheters
- Guiding Wires
- Balloons
- Baskets
Visualization Systems
Energy Devices
Others

Global Endoscopic Retrograde Cholangiopancreatography Market Size by Procedure & CAGR (2025-2032)

Market Overview
Biliary Sphincterotomy
Biliary Stenting
Biliary Dialtation
Pancreatic Sphincterotomy
Pancreatic Duct Stenting
Pancreatic Duct Dilatation

Global Endoscopic Retrograde Cholangiopancreatography Market Size by End Users & CAGR (2025-2032)

Market Overview
Hospitals
Ambulatory Surgery Centers & Clinics
Others

Global Endoscopic Retrograde Cholangiopancreatography Market Size & CAGR (2025-2032)

North America (Product Type, Procedure, End Users)
- US
- Canada
Europe (Product Type, Procedure, End Users)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product Type, Procedure, End Users)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product Type, Procedure, End Users)
- Brazil
- Rest of Latin America
Middle East & Africa (Product Type, Procedure, End Users)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Olympus Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CONMED Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fujifilm Holdings Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
HOYA Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic PLC (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cook Medical (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
STERRIS PLC (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
TeleMed Systems Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DCC Healthcare (Medi-Globe GmbH) (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Huger Medical Instrument Co. Ltd (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SonoScape Medical Corporation (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
KARL STORZ SE & Co. KG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ambu A/S (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
B. Braun Melsungen AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PENTAX Medical (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hitachi Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Canon Medical Systems Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sony Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments